Global Diagnostic Radiopharmaceuticals Competitive Landscape Professional Research Report 2024

Report Format: PDF   |   Report ID: 5685601   |   Published Date: August 2024   |   Pages:  170+  

Research Summary
Diagnostic radiopharmaceuticals are specialized compounds containing a radioactive material and a pharmaceutical component that are used in nuclear medicine imaging procedures. These radiopharmaceuticals emit gamma rays, which can be detected by medical imaging devices like gamma cameras or positron emission tomography (PET) scanners. When introduced into the body, these compounds selectively accumulate in specific organs or tissues, allowing healthcare professionals to visualize physiological processes, metabolic activity, or functional abnormalities. Diagnostic radiopharmaceuticals play a crucial role in various medical imaging tests, such as bone scans, cardiac perfusion studies, and PET scans, providing valuable insights into the inner workings of the body and aiding in the diagnosis and monitoring of diseases and conditions.
According to DIResearch's in-depth investigation and research, the global Diagnostic Radiopharmaceuticals market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Diagnostic Radiopharmaceuticals include Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, SIEMENS, Advanced Accelerator Applications, China Isotope & Radiation, Dongcheng Pharmaceutical Group, Lantheus, Eli Lilly etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Diagnostic Radiopharmaceuticals. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Diagnostic Radiopharmaceuticals market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Diagnostic Radiopharmaceuticals market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Diagnostic Radiopharmaceuticals industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Diagnostic Radiopharmaceuticals Include:
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
SIEMENS
Advanced Accelerator Applications
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly
Diagnostic Radiopharmaceuticals Product Segment Include:
Technetium 99
Fluorine 18
Other
Diagnostic Radiopharmaceuticals Product Application Include:
Oncology
Cardiology
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Diagnostic Radiopharmaceuticals Industry PESTEL Analysis
Chapter 3: Global Diagnostic Radiopharmaceuticals Industry Porter's Five Forces Analysis
Chapter 4: Global Diagnostic Radiopharmaceuticals Major Regional Market Size and Forecast Analysis
Chapter 5: Global Diagnostic Radiopharmaceuticals Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Diagnostic Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Diagnostic Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Diagnostic Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Diagnostic Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Diagnostic Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Diagnostic Radiopharmaceuticals Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Diagnostic Radiopharmaceuticals Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents

1 Diagnostic Radiopharmaceuticals Market Overview

1.1 Product Definition and Statistical Scope

1.2 Diagnostic Radiopharmaceuticals Product by Type

1.2.1 Global Diagnostic Radiopharmaceuticals Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Technetium 99

1.2.3 Fluorine 18

1.2.4 Other

1.3 Diagnostic Radiopharmaceuticals Product by Application

1.3.1 Global Diagnostic Radiopharmaceuticals Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Other

1.4 Global Diagnostic Radiopharmaceuticals Market Revenue Analysis (2019-2030)

1.5 Diagnostic Radiopharmaceuticals Market Development Status and Trends

1.5.1 Diagnostic Radiopharmaceuticals Industry Development Status Analysis

1.5.2 Diagnostic Radiopharmaceuticals Industry Development Trends Analysis

2 Diagnostic Radiopharmaceuticals Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Diagnostic Radiopharmaceuticals Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Diagnostic Radiopharmaceuticals Market Analysis by Regions

4.1 Diagnostic Radiopharmaceuticals Overall Market: 2023 VS 2024 VS 2030

4.2 Global Diagnostic Radiopharmaceuticals Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Region (2019-2024)

4.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Region (2025-2030)

5 Global Diagnostic Radiopharmaceuticals Market Size by Type and Application

5.1 Global Diagnostic Radiopharmaceuticals Market Size by Type

5.2 Global Diagnostic Radiopharmaceuticals Market Size by Application

6 North America

6.1 North America Diagnostic Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Diagnostic Radiopharmaceuticals Market Size by Type

6.4 North America Diagnostic Radiopharmaceuticals Market Size by Application

6.5 North America Diagnostic Radiopharmaceuticals Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Diagnostic Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Diagnostic Radiopharmaceuticals Market Size by Type

7.4 Europe Diagnostic Radiopharmaceuticals Market Size by Application

7.5 Europe Diagnostic Radiopharmaceuticals Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Diagnostic Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Diagnostic Radiopharmaceuticals Market Size by Type

8.4 China Diagnostic Radiopharmaceuticals Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Diagnostic Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Diagnostic Radiopharmaceuticals Market Size by Type

9.4 APAC (excl. China) Diagnostic Radiopharmaceuticals Market Size by Application

9.5 APAC (excl. China) Diagnostic Radiopharmaceuticals Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Diagnostic Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Diagnostic Radiopharmaceuticals Market Size by Type

10.4 Latin America Diagnostic Radiopharmaceuticals Market Size by Application

10.5 Latin America Diagnostic Radiopharmaceuticals Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Diagnostic Radiopharmaceuticals Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Diagnostic Radiopharmaceuticals Market Size by Type

11.4 Middle East & Africa Diagnostic Radiopharmaceuticals Market Size by Application

11.5 Middle East & Africa Diagnostic Radiopharmaceuticals Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Diagnostic Radiopharmaceuticals Market Revenue by Key Manufacturers (2020-2024)

12.2 Diagnostic Radiopharmaceuticals Competitive Landscape Analysis and Market Dynamic

12.2.1 Diagnostic Radiopharmaceuticals Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Cardinal Health

13.1.1 Cardinal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio

13.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 GE Healthcare

13.2.1 GE Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio

13.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Curium Pharma

13.3.1 Curium Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio

13.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Jubilant Pharma

13.4.1 Jubilant Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio

13.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Bracco Imaging

13.5.1 Bracco Imaging Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio

13.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 SIEMENS

13.6.1 SIEMENS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio

13.6.3 SIEMENS Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Advanced Accelerator Applications

13.7.1 Advanced Accelerator Applications Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio

13.7.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 China Isotope & Radiation

13.8.1 China Isotope & Radiation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio

13.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Dongcheng Pharmaceutical Group

13.9.1 Dongcheng Pharmaceutical Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio

13.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Lantheus

13.10.1 Lantheus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio

13.10.3 Lantheus Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Eli Lilly

13.11.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio

13.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Diagnostic Radiopharmaceuticals Industry Chain Analysis

14.2 Diagnostic Radiopharmaceuticals Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Diagnostic Radiopharmaceuticals Typical Downstream Customers

14.4 Diagnostic Radiopharmaceuticals Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: DIResearch
Choose License
Related Reports

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support